Capripox virus antibody and antigen (recombinant protein)

 Download 

Diagnostic anti-Capripox virus antibodies pairs and antigen for animal health (animal Ovines/Sheep infectious disease Lumpy skin disease, sheeppox and goatpox) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Go to Ruminants disease testing products collection >>

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-VT-P089-Ag01	Recombinant Capripox virus protein	$3090.00
GMP-VT-P089-Ab01	Anti-Capripox virus mouse monoclonal antibody (mAb)	$3090.00
GMP-VT-P089-Ab02	Anti-Capripox virus mouse monoclonal antibody (mAb)	$3090.00

Size： 1mg | 10mg | 100mg

Product Description

Cat No.	GMP-VT-P089-Ag01
Product Name	Recombinant Capripox virus protein
Pathogen	Capripox virus
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Capripox virus antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Capripox virus level test of animal Ovines/Sheep infectious disease with Lumpy skin disease, sheeppox and goatpox.
Tag	His
Product description	Recombinant Capripox virus proteinwas expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No.	GMP-VT-P089-Ab01,GMP-VT-P089-Ab02
Pathogen	Capripox virus
Product Name	Anti-Capripox virus mouse monoclonal antibody (mAb)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Capripox virus antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Capripox virus antibodies in Capripox virus level test of animal Ovines/Sheep infectious disease with Lumpy skin disease, sheeppox and goatpox.
Product description	Anti-Capripox virus mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Capripox virus antibodies./td>
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in Sandwich ELISA, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
Formulation	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Pathogen

Supportive Care: As mentioned, there is no specific antiviral treatment for Capripox virus infections in animals. Supportive care is the main approach to manage infected animals. This includes:

Fever Management: To alleviate fever, antipyretic medications may be administered.

Wound Care: Providing appropriate wound care and addressing skin lesions to prevent secondary bacterial infections.

Hydration and Nutrition: Maintaining hydration and ensuring proper nutrition for the affected animals to support their immune response.

Quarantine: In severe cases or during outbreaks, affected animals should be isolated and quarantined. This helps prevent the spread of the virus to other livestock within the herd.

Prevention through Vaccination:

Live Attenuated Vaccines: There are live attenuated vaccines available for Capripox viruses. These vaccines contain weakened forms of the virus, which can stimulate the animal's immune system to produce a protective immune response without causing the disease. These vaccines are often administered to healthy animals to provide immunity.

Inactivated Vaccines: Inactivated vaccines are another option. They contain killed virus particles, which are not capable of causing disease but can still stimulate an immune response. Inactivated vaccines are typically administered to animals at higher risk of infection.

Recombinant Vaccines: Some advanced vaccines may use recombinant DNA technology to produce specific viral antigens, which can be used to immunize animals against Capripox viruses.

Biosecurity Measures:

Quarantine and Isolation: New animals brought into a herd should be quarantined and tested for Capripox virus before being introduced to prevent the introduction of the virus into the herd.

Control of Vectors: Reducing contact with potential vectors, such as mosquitoes and other insects, can help minimize the risk of transmission.

Strict Hygiene Practices: Proper sanitation and disinfection of equipment, facilities, and personnel can help reduce the risk of the virus spreading within and between herds.

Surveillance and Early Detection: Regular monitoring for signs of infection, such as skin lesions, and prompt reporting of suspected cases to veterinary authorities can help in early detection and containment of outbreaks.

It's important to note that the specific preventive measures and vaccination protocols may vary depending on the region, the type of livestock, and the prevalence of Capripox virus. Local veterinary authorities and experts play a crucial role in developing and implementing effective prevention and control strategies based on the specific circumstances.

About GDU